State of Wisconsin Investment Board’s Orion OEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-273,895
Closed -$2.08M 2506
2025
Q3
$2.08M Sell
273,895
-44,875
-14% -$454K ﹤0.01% 1347
2025
Q2
$3.34M Buy
318,770
+46,749
+17% +$529K 0.01% 1079
2025
Q1
$3.52M Buy
272,021
+5,349
+2% +$75.6K 0.01% 1044
2024
Q4
$4.21M Buy
266,672
+19,940
+8% +$337K 0.01% 1016
2024
Q3
$4.39M Hold
246,732
0.01% 1006
2024
Q2
$5.41M Sell
246,732
-1,889
-0.8% -$45.5K 0.01% 883
2024
Q1
$5.85M Sell
248,621
-30,192
-11% -$698K 0.02% 897
2023
Q4
$7.73M Buy
278,813
+36,766
+15% +$844K 0.02% 768
2023
Q3
$5.15M Sell
242,047
-18,373
-7% -$401K 0.02% 908
2023
Q2
$5.53M Sell
260,420
-121,254
-32% -$2.92M 0.02% 918
2023
Q1
$9.96M Sell
381,674
-77,105
-17% -$1.74M 0.03% 585
2022
Q4
$8.17M Sell
458,779
-23,652
-5% -$398K 0.03% 673
2022
Q3
$6.44M Buy
482,431
+2,799
+0.6% +$45.5K 0.02% 798
2022
Q2
$7.45M Buy
479,632
+24,932
+5% +$418K 0.02% 780
2022
Q1
$7.26M Buy
+454,700
New +$7.83M 0.02% 962

Other funds holding OEC

State of Wisconsin Investment Board's OEC Position: Q4 2025 in Review

State of Wisconsin Investment Board sold out of Orion (OEC) in Q4 2025, closing a stake of 273,895 shares — an estimated $2.08M sold.

State of Wisconsin Investment Board first reported a position in OEC in Q1 2022 and held it in 15 quarters. The position peaked at $9.96M in Q1 2023. 174 funds tracked by Wall St. Rank hold OEC as of Q4 2025.

  • State of Wisconsin Investment Board reported no remaining Orion position as of Q4 2025 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 273,895 Orion shares in Q4 2025, an estimated $2.08M.
  • State of Wisconsin Investment Board first reported a position in Orion in Q1 2022 and held it in 15 quarters.
  • State of Wisconsin Investment Board's Orion position peaked at $9.96M in Q1 2023.
  • 174 funds tracked by Wall St. Rank held Orion as of Q4 2025.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2025, filed 17 Feb 2026.